Capgemini applauded by Frost & Sullivan for enabling businesses in the life sciences industry

Photo: Frost & Sullivan.

Frost & Sullivan recognized Capgemini with the 2021 Global Company of the Year Award for digital transformation services within life sciences.

According to Frost & Sullivan, Capgemini’s AI Studio for Drug Discovery is highly scalable, flexible, and based on detailed data science and AI innovation partnerships. This solution enhances quality, improves research and development cycle times, and automates sophisticated processes. Intelligent Clinical Trials improve and transform the planning, modeling, and conducting of clinical trials.

“The advanced solution accelerates time-to-market, reduces costs, and improves patient engagement by leveraging AI, analytics, and digital platforms. The data-driven approach helps customers better understand diseases and patients’ needs, identify therapies with higher potential, and accelerate time-to-market development,” said Unmesh Lal, Industry Analyst, Frost & Sullivan.

Capgemini’s Intelligent Factory features the following:

• Digital manufacturing—enhanced workers, better yield, improved visibility, and predictive maintenance
• Lifecycle management—tech transfer, serialization, digital twin, and product lifecycle management
• Sustainability and a digital backbone to support initiatives
• Digital quality and compliance—automation of quality activities, digital training, in-silico inspections, non-conformance clustering, and automated batch release

“Capgemini provides its groundbreaking, intelligent industry end-to-end capabilities to address the challenges across the life sciences industry,” said Pavel Zhebrouski, Best Practices Research Analyst, Frost & Sullivan. “Capgemini’s mission includes supporting clients while becoming a strategic scaling-up partner through its breadth, depth, and wealth of capabilities.”